Heart Protection In large-scale clinical trials like LEADER, GLP-1s were shown to lower the risk of heart attack, stroke, and cardiovascular death
All Programs Include Every tier provides FDA-approved GLP-1 medication, medical supervision by licensed providers, injection supplies and training, nutritional guidance appropriate to tier, and ongoing support and adjustments
Inflammation Experimental and clinical evidence suggests that NPs may promote inflammatory responses potentially involved in cardiovascular disease progression, particularly atherosclerosis [70] (Fig
10.1080/00031305.1999.10474456 25 EasowB
This hormone then signals the pancreas to release insulin, slows gastric emptying, reduces appetite, and communicates with the brain to create feelings of satiety